Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade

Miloš Táborský1, Tomáš Skála1, Ladislav Dušek2

  • 1Department of Internal Medicine I-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.

PubMed

Insights

Pacemaker implantations in Czech patients increased annually, with higher mortality observed in recipients compared to the general population. Data from the REPACE registry closely matched national health records.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Device Registries

Background:

  • Analysis of mortality data from national health registries and the REPACE registry for Czech pacemaker patients.
  • Examining trends and outcomes associated with pacemaker implantation in a national cohort.

Purpose of the Study:

  • To analyze mortality patterns in Czech patients who received pacemakers between 2010 and 2021.
  • To compare pacemaker implantation data between the REPACE registry and national health records.

Main Methods:

  • Retrospective observational analysis of 82,791 Czech patients undergoing pacemaker implantation from 2010-2021.
  • Utilized data from the REPACE registry and the National Register of Reimbursed Health Services for validation.
  • Categorized pacemakers into single-chamber, dual-chamber, and biventricular devices.

Main Results:

  • Nearly 114,000 pacemakers were implanted, with a steady annual increase except for a dip in 2020 (likely COVID-19 related).
  • Observed 5-year relative survival was 88.6% and 10-year relative survival was 75.9%.
  • Causes of death varied by patient age; pacemaker recipients showed significantly higher mortality than the general population.

Conclusions:

  • Pacemaker implantations in the Czech Republic show a consistent upward trend.
  • Patients with pacemakers exhibit increased mortality risk compared to the general population.
  • The REPACE registry data demonstrates high concordance with national health service records.
Abstract